These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 3244775)

  • 1. Pharmacokinetics of amitriptyline and amitriptylinoxide after intravenous or oral administration in humans.
    Filser JG; Kaumeier S; Brand T; Schanz H; Terlinden R; Müller WE
    Pharmacopsychiatry; 1988 Nov; 21(6):381-3. PubMed ID: 3244775
    [No Abstract]   [Full Text] [Related]  

  • 2. Single oral dose pharmacokinetics of amitriptylinoxide and amitriptyline in humans.
    Kuss HJ; Jungkunz G; Johannes KJ
    Pharmacopsychiatry; 1985 Jul; 18(4):259-62. PubMed ID: 4023050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma and urine kinetics of amitriptyline oxide and its metabolites. Comparison of intravenous infusion and oral administration in volunteers].
    Hutt V; Theodor R; Pabst G; Dilger C; Mosberg H; Fischer W; Jaeger H
    Arzneimittelforschung; 1991 Apr; 41(4):367-72. PubMed ID: 1859509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state plasma levels during antidepressant therapy with amitriptyline and amitriptylinoxide.
    Koch H
    Isr J Psychiatry Relat Sci; 1990; 27(1):48-56. PubMed ID: 2194992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special experiments on central nervous effects of amitriptylinoxide considering pharmacokinetic aspects.
    Wenzl H
    Arzneimittelforschung; 1978; 28(10b):1879-83. PubMed ID: 582515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bioavailability and intestinal secretion of amitriptyline: Role of P-glycoprotein?
    Abaut AY; Chevanne F; Le Corre P
    Int J Pharm; 2007 Feb; 330(1-2):121-8. PubMed ID: 17092666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmortem amitriptyline pharmacokinetics in pigs after oral and intravenous routes of administration.
    Hilberg T; Ripel A; Smith AJ; Slørdal L; Mørland J; Bjørneboe A
    J Forensic Sci; 1998 Mar; 43(2):380-7. PubMed ID: 9544547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind study of the therapeutic efficacy and tolerability of amitriptylinoxide in comparison with amitriptyline.
    Tegeler J; Klieser E; Lehmann E; Heinrich K
    Pharmacopsychiatry; 1990 Jan; 23(1):45-9. PubMed ID: 2179974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M; Chang S; Hellriegel ET
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian changes in the elimination of amitriptyline in rats.
    Rutkowska A; Piekoszewski W; Brandys J
    Pol J Pharmacol Pharm; 1992; 44(6):671-7. PubMed ID: 1305963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites after half-life repeated administration. Comparison with acute administration.
    Coudoré F; Fialip J; Eschalier A; Lavarenne J
    Fundam Clin Pharmacol; 1994; 8(6):525-31. PubMed ID: 7721229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimentation with the intravenous form of amitriptyline in 40 patients].
    Sichel JP; Fonlupt V; Roueff E
    Ann Med Psychol (Paris); 1974 Mar; 1(3):407-20. PubMed ID: 4603533
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multicenter therapy study with the amitriptyline oxide Equilibrin 60--a broad-spectrum antidepressive agent].
    Harrer G; Beinroth AS
    Med Welt; 1983 Dec; 34(51-52):1473-7. PubMed ID: 6669005
    [No Abstract]   [Full Text] [Related]  

  • 14. Amitriptylinoxide: receptor-binding profile compared with other antidepressant drugs.
    Borbe HO; Zierenberg O
    Pharmacopsychiatry; 1985 Sep; 18(5):314-9. PubMed ID: 2996040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
    Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of buflomedil after intravenous and oral administration.
    Rey E; Barrier G; d'Athis P; de Lauture D; Richard MO; Lirzin JP; Sureau C; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):437-41. PubMed ID: 7203720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of dimetindene after intravenous and oral administration to healthy volunteers.
    Arnera V; Wermeille M; Wellman M; Llull JB; Althaus MA; Balant LP
    Arzneimittelforschung; 1990 Dec; 40(12):1346-8. PubMed ID: 2095130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and pharmacokinetics of single oral and intravenous doses of fluconazole in healthy subjects.
    Shiba K; Saito A; Miyahara T
    Clin Ther; 1990; 12(3):206-15. PubMed ID: 2379224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of amitriptyline N-oxide in rats after single and prolonged oral administration.
    Melzacka M; Danek L
    Pharmacopsychiatria; 1983 Jan; 16(1):30-4. PubMed ID: 6828552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.